Nursing fair to prescribe career opportunities for students and graduates Nursing and healthcare providers will gather in Dundee next week for one of the sector’s biggest recruitment fairs. Discovery raises possibility of treating neurological disorders The discovery of a novel class of enzyme in human biology by scientists at the University of Dundee has opened a new area of research that could benefit patients suffering from a range of neurological disorders.
Dolly scientist backs research drive to tackle Parkinson’s disease Professor Sir Ian Wilmut – who led the team that created Dolly the sheep – has backed an initiative to tackle Parkinson’s disease, after being diagnosed with the condition. Working together for health and care across Tayside Chairman of NHS Tayside John Brown joined Chief Executive of NHS Scotland Paul Gray as he met the three Chief Executives of Dundee, Angus and Perth & Kinross Councils in Dundee this week.
University’s business breakfast to serve up fresh opportunities for firms Employers and employees alike are set to benefit from the University of Dundee’s graduate apprenticeship scheme. Graduate apprenticeships provide a new way of learning to degree-level for employees at any stage in their career, combining work-based learning with high-quality education. STAR Awards finalists announced Following almost 700 nominations from staff and the public, the 2018 NHS Tayside Staff Appreciation and Recognition (STAR) Awards finalists have been announced.
Ubiquigent and Forma Therapeutics enter an exclusive R&D collaboration to develop novel DUB inhibitors Dundee, UK, 5th April 2018: Ubiquigent Limited announced today that it has entered into a multi-year strategic R&D collaboration agreement with FORMA Therapeutics for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. Under the terms of the collaboration agreement, Ubiquigent will receive an upfront payment with research support and is eligible for possible additional milestones payments. DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease The University of Dundee’s Drug Discovery Unit (DDU) will collaborate with the not-for-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) and GlaxoSmithKline (GSK) in a bid to discover new pre-clinical drug candidates targeting two parasitic neglected tropical diseases (NTDs), leishmaniasis and Chagas disease.
NHS Tayside supports World Tuberculosis Day To support World Tuberculosis (TB) day on Saturday, 24 March, NHS Tayside held information sessions in Dundee and Perth. Experts and patients meet to tackle Scotland’s chronic pain Experts and patients meet to tackle Scotland’s chronic pain The growing use of opioids to treat chronic pain will be one of the major talking points at a University of Dundee conference today.
Storey sisters share the secrets of neuron birth in latest show The award-winning Storey sisters will launch their latest exhibition in Dundee this week, fusing the worlds of fashion and cellular biology. Signalling study sheds light on conditions from alopecia to cancer Researchers from the University of Dundee and the Francis Crick Institute have made a significant discovery about a cellular pathway associated with developmental defects and a myriad of diseases ranging from alopecia to colorectal cancer.
Dundee ranked among UK’s best for student experience The University of Dundee has been ranked among the top universities in the United Kingdom – and 2nd in Scotland – in the 2018 Times Higher Education Student Experience Survey. £8000 scholarships open to pupils with a degree in their sights School pupils in Dundee looking to move on to higher education are invited to apply for scholarships worth £8000 over the duration of a four-year degree at the University of Dundee
Professor Nicola Stanley-Wall elected a Fellow of the Royal Society of Edinburgh Professor Nicola Stanley-Wall, of the University of Dundee, has been elected a Fellow of the Royal Society of Edinburgh (RSE). Professor Stanley-Wall is Head of the Division of Molecular Microbiology in the School of Life Sciences at the University.